Effects of chronic morphine and N(6)-cyclopentyl-adenosine administration on kainic acid-induced status epilepticus

Epilepsy Research
A Cano-MartínezL Rocha

Abstract

The aim of the present study was to investigate if the upregulation of mu or A(1) receptors modifies the expression of the kainic acid (KA)-induced status epilepticus (SE). Male Wistar rats received one of the following treatments: saline solution (SS) (1 ml/kg, i.p. for 7 days); morphine (M) (20 mg/kg, i.p. for 7 days) or N(6)-cyclopentyl-adenosine (CPA) (1 mg/kg, i.p. for 9 days). Twenty-four hours after the last administration rats were sacrificed. Membranes were obtained mu and and A(1) receptor binding experiments were carried out. Furthermore, an injection of SS (1 ml/kg, i.p.) or KA (10 mg/kg, i.p.) was applied in rats pretreated chronically with M, CPA or SS, 48 h after the last administration. Seizure activity, death rate and a postictal explosive motor behavior were evaluated after KA administration. Chronic M administration increased mu receptor number in hippocampus (115%) and cortex (265%), whereas chronic CPA treatment enhanced A(1) receptor number in hippocampus (55%), amygdala (39%) and cortex (51%). The pretreatment with M facilitated the KA-induced SE and reduced the death rate as well as the postictal explosive motor behavior. The pretreatment with CPA delayed the SE presentation, increased the death rate and...Continue Reading

References

Jan 31, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·R SchulzA Herz
Nov 11, 1991·Epilepsy Research·L RochaR F Ackermann
Aug 1, 1990·Epilepsy Research·K WhitcombR F Berman
Jul 1, 1989·Epilepsy Research·A Fernández-GuardiolaJ M Calvo
Jan 1, 1987·Progress in Neuro-psychopharmacology & Biological Psychiatry·S Caldecott-Hazard, J Engel
Jun 1, 1988·Naunyn-Schmiedeberg's Archives of Pharmacology·M J LohseM Grifantini
Sep 1, 1985·Epilepsia·M DragunowR Laverty
Nov 1, 1969·Experimental Neurology·G V GoddardC K Leech
Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
Jan 1, 1994·Progress in Neurobiology·G Sperk
Apr 1, 1993·Progress in Neurobiology·J S HongC L Mitchell
Feb 11, 1999·Biochemical Pharmacology·B Pavan, A P IJzerman
Jul 10, 1999·Journal of Physiology, Paris·J Tchekalarova, V Georgiev
Nov 17, 1999·The European Journal of Neuroscience·Y MatsuokaT Taniguchi

❮ Previous
Next ❯

Citations

Jan 22, 2003·Peptides·Richard J Bodnar, Maria M Hadjimarkou
Jun 28, 2003·Natural Product Reports·Kenneth W Bentley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.